T. Rowe Price Investment Management’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $314K | Sell |
182,436
-1,747,584
| -91% | -$3.01M | ﹤0.01% | 655 |
|
|
2025
Q1 | $6.43M | Sell |
1,930,020
-3,904,436
| -67% | -$13M | ﹤0.01% | 579 |
|
|
2024
Q4 | $43.2M | Sell |
5,834,456
-26,823
| -0.5% | -$198K | 0.03% | 428 |
|
|
2024
Q3 | $55M | Buy |
5,861,279
+3,810,779
| +186% | +$35.8M | 0.03% | 393 |
|
|
2024
Q2 | $16.4M | Buy |
2,050,500
+737,161
| +56% | +$5.91M | 0.01% | 519 |
|
|
2024
Q1 | $19.5M | Buy |
+1,313,339
| New | +$19.5M | 0.01% | 504 |
|